현대약품

004310KOSPI의약품 제조업

42.0 / 100

Reference Date: 2026-04-13

Financial Score11.5 / 40

News Sentiment11.5 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is low with sound financial health but PER raises overvaluation concerns. Declined 6.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Hyundai Pharm focuses on the production and sale of prescription and OTC pharmaceuticals, food, cosmetics, and medical devices, supplying products such as hypertension medication Tenolmin, hair loss treatment Minoxil, and dietary fiber beverage Mieyro Haiiba both domestically and internationally. The company has established a competitive edge in the functional cosmetics market through its brand Labcle, which emphasizes eco-friendly ingredients and sustainable packaging, aligning with global green consumption trends.

Number of Employees

399people

Average Salary

71.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

89.90Industry Average 14.800.0Point

6.1x industry avg (risky)

PBR

3.36Industry Average 1.040.0Point

3.2x industry avg (risky)

ROE

3.12Industry Average 4.422.5Point

Below industry avg

Debt Ratio

11.82Industry Average 11.984.0Point

In line with industry avg

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲3.2% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲1051.5% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 3.2% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 1Neutral 1Negative 1Average Sentiment Score 41.7

Negative
현대약품, 고혈압·고지혈증 복합제 3상 자진 중단 [공시pick]
현대약품이 개발 중이던 고혈압·고지혈증 복합제 'HODO-2224'의 임상 3상 시험을 규제 환경 변화에 따라 자진 중단하고 개발 전략을 조정할 방침이라고 공시했습니다.
Neutral
한승현 로완 대표 “日 소프트뱅크와 치매 정복...올해 매출 6배 성장...
로완 대표가 일본 소프트뱅크와 치매 정복을 위해 협력하고 올해 매출 6배 성장을 목표로 한다는 소식으로, 현대약품에 대한 직접적인 영향은 중립적입니다.
Positive
‘탈모 커뮤니티 1위’ 현대약품 마이녹셀 샴푸, 올리브영서 만난다
현대약품의 두피·탈모 케어 전문 브랜드 '마이녹셀 포어 클렌징 스칼프 샴푸'가 올리브영 맨즈 큐레이션 제품으로 참여하며 유통 채널을 확대했습니다.

Detailed Momentum

52-week position5.0Point

52w mid range (48%)

Current 8,630Won52-week high 14,34052-week low 3,260

1-month return2.0Point

1m -6.90% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral투자판단관련주요경영사항2026-03-26